Goldman Sachs analysts have lowered their forecast for the S&P 500 this year following a broad sell-off to start this week ...

The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...

Three is a trend, as RBC Capital Markets joined Goldman Sachs and Yardeni Research in slashing S&P 500 price targets.

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...

Cloudflare (NYSE:NET – Free Report) had its price target decreased by The Goldman Sachs Group from $183.00 to $161.00 in a ...

Goldman Sachs has big price targets on two high-yield tobacco stocks. They can provide investors with reliable streams of ...

Goldman Sachs is the latest economic forecasting team to downgrade its outlook as Trump's tariffs are expected to weigh on ...

Seres Therapeutics (NASDAQ:MCRB – Free Report) had its price objective trimmed by The Goldman Sachs Group from $1.00 to $0.75 in a report released on Friday,Benzinga reports. The brokerage currently ...

Goldman Sachs on Monday downgraded its 2025 projection for U.S. economic growth to 1.7% from 2.4%, citing its outlook on the ...

Goldman Sachs is the latest Wall Street firm to grow more concerned about the path forward for the US economy as President Trump's tariff policies become reality. In a research note on Monday ...

Goldman Sachs cuts S&P 500 target to 6,200 for 2025, citing market uncertainty, tariffs, and Magnificent Seven stock struggles.

Among agricultural inputs, seeds remain the most resilient business in a weaker commodity cycle, according to Goldman. The firm sees strong pricing power and cost advantages in Corteva’s North ...